Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering and corporate finance. The firm leverages its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. The firm’s strength stems from its multi-disciplinary, industry experts who draw from their broad relationships and a wide range of scientific, operational, strategic and transactional expertise across the value chain. Comprised of former CEOs, business development executives, venture capitalists, PhD/MD-level scientists and clinicians, and experienced commercialization experts, our team is driven to propel innovation from bench to bedside. Outcome Capital is proud of its unique culture of intellectual agility and openness, data-driven perspectives, strategic thinking, and commitment to teamwork. We are devoted to providing unmatched advisory services to our clients and share an uncompromised dedication to the life sciences and healthcare industry success. The Outcome Capital Difference - - Creating Extraordinary Outcomes. Maximizing your company’s value by bringing… - Unique Insights - In-depth Industry Experience & Networks - Personal Commitment to Clients - Exceptional Record of Success Outcome provides comprehensive strategic advisory and investment banking services in the following areas: Life Sciences - Pharma - Medical Devices - Biotech - Healthcare Services - Diagnostics - Tools and Research - Pharma services - Digital health
View Top Employees from Outcome CapitalWebsite | http://www.outcomecapital.com |
Revenue | $5 million |
Funding | $150000 |
Employees | 40 (27 on RocketReach) |
Founded | 1998 |
Address | 99 High St. Suite 2900, Boston, Massachusetts 02110, US |
Phone | (617) 431-4886 |
Fax | (703) 225-1515 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Investment Banking, Finance General, Aerospace, Mergers and Acquisitions, Finance, Science and Engineering, Private Equity and Debt Placement, Financial Services, Strategic Advisory, Life Science, Biotechnology |
Web Rank | 5 Million |
Keywords | Wwc Capital Group, Outcome Capital, Thomas Busby Outcome Capital, "Cell Factory" Market Growth, Beryllium Boston |
Competitors | Consilium Partners, Fairmount Partners, Ferghana Partners, Greif & Co., Progress Partners |
SIC | SIC Code 621 Companies, SIC Code 62 Companies |
NAICS | NAICS Code 52311 Companies, NAICS Code 523110 Companies, NAICS Code 523 Companies, NAICS Code 52 Companies, NAICS Code 5231 Companies |
Looking for a particular Outcome Capital employee's phone or email?
The Outcome Capital annual revenue was $5 million in 2024.
Ellen Baron is the Managing Director; Biopharmaceuticals of Outcome Capital.
27 people are employed at Outcome Capital.
Outcome Capital is based in Boston, Massachusetts.
The NAICS codes for Outcome Capital are [52311, 523110, 523, 52, 5231].
The SIC codes for Outcome Capital are [621, 62].